You are here

  • Home
  • Online First
  • Questions around a case of in utero thrombosis in a premature child, concerning the management of anticoagulant treatments

Article Text

Article menu
Download PDFPDF
Case report
Questions around a case of in utero thrombosis in a premature child, concerning the management of anticoagulant treatments
  1. Delphine Gerard1,
  2. Arnaud Callies2,
  3. Laure Simon2,
  4. Catherine Ternisien3,
  5. Sonia Prot-Labarthe1
  1. 1Pharmacie Clinique Hôtel Dieu, CHU Nantes, Nantes, Pays de la Loire, France
  2. 2Néonatologie, CHU Nantes, Nantes, Pays de la Loire, France
  3. 3Hématologie, CHU Nantes, Nantes, Pays de la Loire, France
  1. Correspondence to Delphine Gerard, Pharmacie Clinique Hôtel Dieu, CHU Nantes, Nantes 44000, Pays de la Loire, France; delphine.ggrdt{at}gmail.com

Abstract

We report the case of a preterm infant presenting a thrombosis, discovered on ultrasound at 22 weeks of gestational age and confirmed at birth following additional examinations. We describe the anticoagulant treatment of this patient by intravenous enoxaparin, tinzaparin and rivaroxaban, from questioning to practice.

  • PEDIATRICS
  • Anticoagulants
  • Case Reports
  • NEONATOLOGY
  • Thromboembolism
  • Administration, Intravenous
  • Drug Monitoring

Data availability statement

All data relevant to the study are included in the article.

https://doi.org/10.1136/ejhpharm-2023-003826

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Data availability statement

    All data relevant to the study are included in the article.

    View Full Text